Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Syra Health Corp. Class A Common Stock (SYRA)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
10/09/2025: SYRA (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Analysis of Past Performance
Type Stock | Historic Profit -44.59% | Avg. Invested days 20 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 10/09/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.19M USD | Price to earnings Ratio - | 1Y Target Price 1.8 |
Price to earnings Ratio - | 1Y Target Price 1.8 | ||
Volume (30-day avg) - | Beta - | 52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 |
52 Weeks Range 0.03 - 1.71 | Updated Date 06/29/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -0.32 |
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -34.43% | Operating Margin (TTM) -25.48% |
Management Effectiveness
Return on Assets (TTM) -42.21% | Return on Equity (TTM) -94.29% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value -1166862 | Price to Sales(TTM) 0.15 |
Enterprise Value -1166862 | Price to Sales(TTM) 0.15 | ||
Enterprise Value to Revenue 0.5 | Enterprise Value to EBITDA - | Shares Outstanding 11339200 | Shares Floating 8861182 |
Shares Outstanding 11339200 | Shares Floating 8861182 | ||
Percent Insiders 13.48 | Percent Institutions 1.49 |
Upturn AI SWOT
Syra Health Corp. Class A Common Stock
Company Overview
History and Background
Syra Health Corp. was founded in 2020 and went public in 2023, focusing on providing technology-enabled healthcare solutions. They aim to improve access to care and patient outcomes through telehealth and related services.
Core Business Areas
- Behavioral Health Services: Provides telehealth-based behavioral health services, including therapy and counseling.
- Healthcare Technology Solutions: Develops and implements technology solutions for healthcare providers, focusing on telehealth platforms and data analytics.
- Managed Care and Population Health: Offers managed care and population health services to improve patient outcomes and reduce healthcare costs.
Leadership and Structure
The leadership team consists of the CEO, CFO, and other key executives. The organizational structure includes departments for technology, operations, finance, and business development.
Top Products and Market Share
Key Offerings
- Telehealth Platform: A proprietary telehealth platform that enables virtual consultations and remote patient monitoring. Limited market share data available given recent IPO. Competitors: Teladoc Health (TDOC), Amwell (AMWL).
- Data Analytics Services: Offers data analytics services to healthcare providers to identify trends, improve patient care, and optimize operations. Limited market share data available given recent IPO. Competitors: Optum (UNH), Cerner (ORCL).
- Behavioral Health Solutions: Provide mental health and behavioral health therapy. Market share is not available for this specific product. Competitors: Talkspace (TALK), Lyra Health.
Market Dynamics
Industry Overview
The telehealth industry is experiencing rapid growth driven by increasing demand for remote healthcare services and advancements in technology. The industry is competitive, with both established players and emerging startups.
Positioning
Syra Health Corp. is positioned as a technology-enabled healthcare provider focused on telehealth and data analytics. It aims to differentiate itself through its proprietary platform and integrated services.
Total Addressable Market (TAM)
The global telehealth market is estimated to reach hundreds of billions of dollars. Syra Health Corp. is positioned to capture a portion of this TAM through its telehealth platform, behavioral health offering, and data analytics capabilities, although precise penetration within this TAM is uncertain.
Upturn SWOT Analysis
Strengths
- Proprietary telehealth platform
- Focus on technology-enabled healthcare
- Experienced leadership team
- Potential for rapid growth in the telehealth market
Weaknesses
- Limited operating history
- Small market share compared to larger competitors
- Dependence on key personnel
- Need for substantial capital investment
Opportunities
- Expanding telehealth adoption
- Increasing demand for data analytics in healthcare
- Strategic partnerships with healthcare providers
- Acquisition of complementary businesses
Threats
- Competition from larger, established players
- Changes in healthcare regulations
- Cybersecurity risks
- Economic downturn
Competitors and Market Share
Key Competitors
- Teladoc Health (TDOC)
- Amwell (AMWL)
- Talkspace (TALK)
Competitive Landscape
Syra Health Corp. faces intense competition from larger, more established players in the telehealth and healthcare technology markets. Its competitive advantage lies in its proprietary platform and focus on technology-enabled healthcare.
Growth Trajectory and Initiatives
Historical Growth: Historical growth data is limited due to the company's recent IPO, but it has potential for rapid growth in the telehealth market.
Future Projections: Future growth projections depend on successful execution of its business plan and market conditions. Analyst estimates may be limited given the company's recent IPO.
Recent Initiatives: Recent initiatives include expanding its telehealth platform, forming strategic partnerships with healthcare providers, and expanding its sales and marketing efforts.
Summary
Syra Health is a relatively new player in the telehealth and healthcare technology space. Its strengths lie in its proprietary telehealth platform, focus on technology-enabled healthcare, and experienced leadership team. However, the company needs to overcome the challenges of limited operating history, small market share, and competition from larger players to be successful in the market.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Press Releases
- Company Website
- Market Research Reports
- SEC Filings
Disclaimers:
The data and analysis provided are based on publicly available information and analyst estimates. This is not financial advice, and investment decisions should be made after consulting with a financial professional.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Syra Health Corp. Class A Common Stock
Exchange NASDAQ | Headquaters Carmel, IN, United States | ||
IPO Launch date 2023-09-29 | Interim CEO, CFO, COO & Director Ms. Priya Prasad | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 57 | Website https://www.syrahealth.com |
Full time employees 57 | Website https://www.syrahealth.com | ||
Syra Health Corp., a healthcare services company, provides solutions in behavioral and mental health, population health, digital health, health education, and healthcare workforce in the United States. The company offers Syrenity, a behavioral and mental health application that identifies and prevents the progression of negative factors that can influence individuals' mental health by offering targeted assignments, education, and monitoring symptoms, as well as providing interventions, such as cognitive behavioral therapy and mindfulness techniques; digital health products, including SyraBot, a chatbot to foster connectivity and engagement throughout individuals' care journeys offering members access to necessary information via its AI-powered customer support chat system; and CarePlus, an electronic medical records solution for small to mid-sized healthcare organizations. It also provides analytics as a service, analytics as a service, epidemiology, and health equity analytics solutions. In addition, the company offers medical communications, patient education, and healthcare training; and recruits nurses and allied health professionals for long-term fixed contract positions at hospitals and healthcare facilities. It serves mental health hospitals and organizations, including government agencies, integrated health networks, managed care entities, and pharmaceutical manufacturers. The company was incorporated in 2020 and is headquartered in Carmel, Indiana.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.